HEALTH CARE:
BIOTECHNOLOGY & LIFE SCIENCES
SIC: PHARMACEUTICAL PREPARATIONS
Kiniksa Pharmaceuticals, Ltd. operates as a clinical-stage biopharmaceutical company. The Company focuses on discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating diseases with significant unmet medical need. Kiniksa Pharmaceuticals serves patients worldwide.
| Q2 2019 | All Institutions | Hedge Funds 1 |
|---|---|---|
| To trade KNSA now: | |
|
| Filers who had this stock in their top 10: | 0 | 0 (0.0%) |
| 13F Filers holding this stock: | 61 | 13 (1.34%) |
| Aggregate 13F shares on 06/30/2019: | 16.569 Million | 7.601 Million |
| Aggregate 13F shares on 03/31/2019: | 16.321 Million | 7.708 Million |
| Percent change: | 1.52% | -1.39% |
| Funds creating new positions: | 13 | 2 |
| Funds Adding to an existing position: | 25 | 6 |
| Funds closing out their position: | 6 | 3 |
| Funds reducing their position: | 14 | 3 |
| 1 hedge funds as identified by whalewisdom.com through public filings. | ||
View recent insider trading info
Kiniksa Pharmaceuticals Ltd Chart by YCharts
Please sign in first
none
none
10 Thousand total shares from 1 transactions
| Insider Name | Type | Last Reported Shares Held | Last Reported Date | Filings in past year |
|---|---|---|---|---|
|
0 | 2019-10-10 | 2 | |
|
POPOVITS KIMBERLY J PRESIDENT AND CEO |
|
116,734 | 2019-10-08 | 1 |
|
PAOLINI JOHN F. SVP & CHIEF MEDICAL OFFICER |
|
10,000 | 2019-10-07 | 3 |
|
QUART BARRY D CHIEF EXECUTIVE OFFICER |
|
94,652 | 2019-10-03 | 1 |
|
HEBERLIG CHRIS EVP & CFO |
|
0 | 2019-09-17 | 2 |
|
PATEL SANJ K CHAIRMAN & CEO |
|
0 | 2019-09-17 | 2 |
|
MAHONEY STEPHEN F. PRESIDENT & COO |
|
0 | 2019-09-17 | 2 |
|
BEETHAM THOMAS W. EVP & CHIEF LEGAL OFFICER |
|
0 | 2019-09-17 | 2 |
|
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) |
|
4,123,266 | 2019-06-27 | 0 |
|
0 | 2019-06-27 | 2 | |
|
0 | 2019-06-25 | 1 | |
|
0 | 2019-05-29 | 1 | |
|
|
0 | 2019-01-28 | 0 | |
|
CORMORANT ASSET MANAGEMENT, LP |
|
No longer subject to file | 2018-10-31 | 0 |
|
CORMORANT ASSET MANAGEMENT, LP CORMORANT GLOBAL HEALTHCARE MASTER FUND, LP |
|
0 | 2018-10-30 | 0 |
|
No longer subject to file | 2018-07-23 | 0 | |
|
0 | 2018-05-23 | 0 |
| Reporting Owners | Transaction Date | Transaction Code | Shares | Share Price | Acquired or Disposed | Shares Owned Following Transaction | Combined shares owned after filing | Direct/Indirect Ownership | 10b-5 |
|---|---|---|---|---|---|---|---|---|---|
| 2019-10-07 | M | 10,000 | $1.86 | a | 10,000 | 10,000.00 | direct | ||
| 2019-10-07 | M | 10,000 | d | 217,574 | 10,000.00 | direct | |||
| 2019-09-17 | A | 50,000 | a | 50,000 | 0.00 | direct | |||
| 2019-09-17 | A | 45,000 | a | 45,000 | 0.00 | direct | |||
| 2019-09-17 | A | 190,000 | a | 190,000 | 0.00 | direct | |||
| 2019-09-17 | A | 46,000 | a | 46,000 | 0.00 | direct | |||
| 2019-09-17 | A | 82,000 | a | 82,000 | 0.00 | direct |
